Noveris Health Sciences is trading 10% lower at CA$0.04, with the specific catalyst unclear. - The price context shows the decline during live trading on October 28, following a CA$0.05 close on October 27. - No company-specific announcement explaining the drop was found; the latest release listed on the company news page is dated September 9, 2026. - Biotech sector strength is not a clear explanation, and broader market context is mixed.